Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment

NCT06788626 is registered in ClinicalTrials.gov with Wei Hu as lead sponsor.

NCT NCT06788626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06788626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment
Lead sponsor
Wei Hu
Phase
Phase 3
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
February 29, 2028
Enrollment
390 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, endovascular treatment, large vessel occlusion, neuroprotective drugs